Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.
Whelan CD, Altmann A, Botía JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, França W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodríguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargalló N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blümcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kälviäinen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O'Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM. · 2018
Read Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. by Whelan CD, Altmann A, Botía JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, França W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodríguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargalló N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blümcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kälviäinen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O'Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5837616.txt.
Introduction
Whelan and co-authors map brain structure across the common epilepsies in a worldwide imaging study. Their report appeared in Brain. It pools MRI scans through the ENIGMA consortium. Earlier single-center studies disagreed on what changes.
Scans from 24 centers now give a firmer picture. The thalamus shrank across epilepsy syndromes, a shared mark. Cortical thickness differed widely from controls as well. Each syndrome still kept its own pattern of change. The map gives future studies a baseline for tracking progression. It may also point to pathways the syndromes share.
Catalog record
| CREATOR | Whelan CD, Altmann A, Botía JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, França W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodríguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargalló N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blümcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kälviäinen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O'Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study By Christopher D Whelan, Andre Altmann, Juan A Botía, Neda Jahanshad, Derrek P Hibar, Julie Absil, Saud Alhusaini, Marina K M Alvim, Pia Auvinen, Emanuele Bartolini, Felipe P G Bergo, Tauana Bernardes Published in: Brain DOI: 10.1093/brain/awx341 ABSTRACT Structural MRI abnormalities are inconsistently reported in epilepsy. In the largest neuroimaging study to date, Whelan et al. report robust structural alterations across and within epilepsy syndromes, including shared volume loss in the thalamus, and widespread cortical thickness differences. The resulting neuroanatomical map will guide prospective studies of disease progression. Keywords: epilepsy, MRI, thalamus, precentral gyrus INTRODUCTION Epilepsy is a prevalent neurological disorder, comprising many different syndromes and conditions, affecting 0.6–1.5% of the population worldwide (Bell et al., 2014). Approximately one-third of affected individuals do not respond to antiepileptic drug therapy (French, 2007). Alternative treatment options may not be appropriate (Englot et al., 2011), and are not always effective (Téllez-Zenteno et al., 2005; Englot et al., 2011). The identification of shared biological disease pathways may help elucidate diagnostic and prognostic biomarkers and therapeutic targets, which, in turn, could help to optimize individual treatment (Pitkänen et al., 2016). However, disease biology remains unexplained for most cases—especially in commonly occurring epilepsies. Epilepsy is a network disorder typically involving widespread structural alterations beyond the putative epileptic focus (Bernhardt et al., 2015; Vaughan et al., 2016). Hippocampal sclerosis is a common pathological substrate of mesial temporal lobe epilepsy (MTLE), but extrahippocampal abnormalities are also frequently observed in MTLE, notably in the thalamus (Keller and Roberts, 2008; Coan et al., 2014; Alvim et al., 2016) and neocortex (Keller and Roberts, 2008; Bernhardt et al., 2009b, 2010; Blanc et al., 2011; Labate et al., 2011; Vaughan et al., 2016). Neocortical abnormalities are also reported in idiopathic generalized epilepsies (IGE) (Bernhardt et al., 2009a), and many childhood syndromes (O’Muircheartaigh et al., 2011; Vollmar et al., 2011; Ronan et al., 2012; Overvliet et al., 2013). Thus, common epilepsies may be characterized by shared disturbances in distributed cortico-subcortical brain networks (Berg et al., 2010), but the pattern, consistency and cause of these disturbances, and how they relate to functional decline (Vlooswijk et al., 2010; Bernasconi, 2016; Nickels et al., 2016), are largely unknown. Currently, we lack reliable data from large cross-sectional neuroimaging, brain tissue, or biomarker studies in the common epilepsies. Brain tissue is not available from large cohorts of patients: common forms of epilepsy are often unsuitable for surgical treatment, so biopsied tissues are simply unavailable in sufficient numbers for research into disease biology. Brain-wide post-mortem studies also require extensive effort for comprehensive analysis. MRI offers detailed information on brain structure, but MRI measures from groups of individuals with and without epilepsy are not always consistent. For example, MTLE is associated with hippocampal sclerosis in up to 70% of brain MRI scans (Blümcke et al., 2013). However, the effects of laterality, and the extent of extrahippocampal grey matter loss are inconsistently reported in studies of left versus right MTLE (Kemmotsu et al., 2011; Liu et al., 2016). Similarly, abnormalities of the basal ganglia, hippocampus, lateral ventricles, and neocortex have all been reported in IGE (Betting et al., 2006), but most alterations are non-specific, and visual inspection of clinical MRI in IGE is typically normal (Woermann et al., 1998). Genome-wide association studies (GWAS) have identified genetic variants associated with complex epilepsies by ‘lumping’ different epilepsy types together (International League Against Epilepsy Consortium on Complex Epilepsies, 2014), but MRI studies are typically of smaller scale, and have not widely explored whether distinct epilepsy syndromes share common structural abnormalities. There are many sources of inconsistency in previously reported MRI findings. First, epileptic seizures and syndromes are diverse; classifications are often revised and contested (Berg et al., 2010; Scheffer et al., 2017). Second, most cross-sectional brain imaging studies are based on small samples (typically <50 cases), limiting the power to detect subtle group differences (Button et al., 2013). Third, variability in scanning protocols, image processing, and statistical analysis may affect the sensitivity of brain measures across studies. The Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Consortium was formed to address these issues (Bearden and Thompson, 2017). ENIGMA is a global initiative, combining large samples with coordinated image processing, and integrating genomic and MRI data across hundreds of research centres worldwide. Prior ENIGMA studies have identified genetic variants associated with variations in brain structure (Stein et al., 2012; Hibar et al., 2015, 2017a; Adams et al., 2016), and have reliably characterized patterns of brain abnormalities in schizophrenia (van Erp et al., 2016), major depression (Schmaal et al., 2016), obsessive compulsive disorder (Boedhoe et al., 2017), attention deficit hyperactivity disorder (Hoogman et al., 2017), and many other brain illnesses (Thompson et al., 2017). Large-scale, collaborative initiatives such as ENIGMA may improve our understanding of epilepsy, helping clinicians make more informed decisions and provide personalized treatment strategies (Ben-Menachem, 2016). Thus, we formed the Epilepsy Working Group of ENIGMA (‘ENIGMA-Epilepsy’) to apply coordinated, well-powered studies of imaging and genetic data in epilepsy. Here, in the largest analysis of structural brain abnormalities in epilepsy to date, we ranked effect sizes for 16 subcortical and 68 cortical brain regions in 2149 individuals with epilepsy and 1727 healthy controls, using harmonized image processing, quality control, and meta-analysis. First, we grouped all epilepsies together, to determine whether biologically distinct syndromes show robust, common structural deficits. Second, we assessed a well-characterized form of epilepsy: MTLE with hippocampal sclerosis, analysing patients with left- and right-sided hippocampal sclerosis as independent groups. Third, we examined another major set of epilepsy syndromes: IGE. Finally, we studied all remaining epilepsies as a combined subgroup, to understand the relative contributions of IGE, MTLE-L, MTLE-R, and all other syndromes on shared patterns of structural compromise. We tested how age at scan, age of onset, and epilepsy duration affected brain structural measures. Based on existing neuroimaging (Gotman et al., 2005; Bernhardt et al., 2009a; Liu et al., 2016), neurophysiological (Gotman et al., 2005), neuropathological (Thom et al., 2009), and genetic data (International League Against Epilepsy Consortium on Complex Epilepsies, 2014), we predicted that (i) biologically distinct epilepsy syndromes would exhibit shared patterns of structural abnormalities; (ii) MTLEs with left or right hippocampal sclerosis would show distinct patterns of hippocampal and extrahippocampal structural deficits; and (iii) IGEs would also display subcortical volume and cortical thickness differences, compared to healthy controls. MATERIALS AND METHODS Each centre received approval from their local institutional review board or ethics committee. Written informed consent was provided according to local requirements (Supplementary Table 1). Experimental design Participants Twenty-four cross-sectional samples from 14 countries were included in the study, totalling 2149 people with epilepsy and 1727 research centre-matched healthy control subjects (Fig. 1 and Table 1). The locations, dates, and periods of participant recruitment are provided in Supplementary Table 1. An epilepsy specialist assessed seizure and syndrome classifications at each centre, using International League Against Epilepsy terminology (Berg et al., 2010). Participants were aged 18–55. [Figure: Study flowchart. ILAE = International League Against Epilepsy; MOU = memorandum of understanding.] [Table: ENIGMA - Epilepsy Working Group demographics, including age (in years), mean age at onset of epilepsy (in years), mean duration of illness (in years), sex, and